PDCD1 and T-cell non-Hodgkin lymphoma: Notably, PMA treatment was confirmed to cause a significant increase of PD-1 expression in the tumors of T-cell lymphoma model mice to 153.0 ± 40.3% compared to vehicle-injected controls (P = 0.07; Figure 6(b)).